HRT Financial’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$44K Buy
2024
Q1
Sell
2023
Q4
$47K Buy
2023
Q2
Sell
2023
Q1
$19K Buy
2022
Q3
Sell
2022
Q2
$35K Buy
2021
Q3
Sell
2021
Q2
$181K Buy
2020
Q1
Sell
2019
Q4
$53K Buy